AU695266B2 - Topical fibrinogen complex - Google Patents

Topical fibrinogen complex Download PDF

Info

Publication number
AU695266B2
AU695266B2 AU19937/95A AU1993795A AU695266B2 AU 695266 B2 AU695266 B2 AU 695266B2 AU 19937/95 A AU19937/95 A AU 19937/95A AU 1993795 A AU1993795 A AU 1993795A AU 695266 B2 AU695266 B2 AU 695266B2
Authority
AU
Australia
Prior art keywords
composition
concentration
thrombin
fibrinogen
plasma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU19937/95A
Other languages
English (en)
Other versions
AU1993795A (en
Inventor
Melaine Alpern
Stanley T Enomoto
Cataline M Garanchon
Shu-Len Liu
Samia S Mankarious
William R. Thomas
Daphne C Tse
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22860054&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU695266(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxter International Inc filed Critical Baxter International Inc
Publication of AU1993795A publication Critical patent/AU1993795A/en
Application granted granted Critical
Publication of AU695266B2 publication Critical patent/AU695266B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • C07K14/75Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/043Mixtures of macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10Polypeptides; Proteins
    • A61L24/106Fibrin; Fibrinogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU19937/95A 1994-03-18 1995-03-17 Topical fibrinogen complex Ceased AU695266B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22915894A 1994-03-18 1994-03-18
US229158 1994-03-18
PCT/US1995/003451 WO1995025748A1 (en) 1994-03-18 1995-03-17 Topical fibrinogen complex

Publications (2)

Publication Number Publication Date
AU1993795A AU1993795A (en) 1995-10-09
AU695266B2 true AU695266B2 (en) 1998-08-13

Family

ID=22860054

Family Applications (1)

Application Number Title Priority Date Filing Date
AU19937/95A Ceased AU695266B2 (en) 1994-03-18 1995-03-17 Topical fibrinogen complex

Country Status (5)

Country Link
EP (1) EP0699210A1 (ja)
JP (1) JP2896235B2 (ja)
AU (1) AU695266B2 (ja)
CA (1) CA2162997A1 (ja)
WO (1) WO1995025748A1 (ja)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1240200B1 (en) * 1999-12-23 2009-06-03 Csl Limited Separation of fibrinogen from plasma proteases
GB0216001D0 (en) 2002-07-10 2002-08-21 Nat Blood Authority Process and composition
AU2004208038B2 (en) 2003-01-30 2007-09-06 Prochon Biotech Ltd. Freeze-dried fibrin matrices and methods for preparation thereof
US7067123B2 (en) 2003-04-29 2006-06-27 Musculoskeletal Transplant Foundation Glue for cartilage repair
US7901457B2 (en) 2003-05-16 2011-03-08 Musculoskeletal Transplant Foundation Cartilage allograft plug
DE102004009400A1 (de) 2004-02-24 2005-09-08 Zlb Behring Gmbh Fibrinogen Reinigung
US7335508B2 (en) 2004-07-22 2008-02-26 Prochon Biotech Ltd. Porous plasma protein matrices and methods for preparation thereof
US7837740B2 (en) 2007-01-24 2010-11-23 Musculoskeletal Transplant Foundation Two piece cancellous construct for cartilage repair
US20090319045A1 (en) 2004-10-12 2009-12-24 Truncale Katherine G Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles
FR2887883B1 (fr) 2005-06-29 2007-08-31 Lab Francais Du Fractionnement Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
US7815926B2 (en) 2005-07-11 2010-10-19 Musculoskeletal Transplant Foundation Implant for articular cartilage repair
EP1926459B1 (en) 2005-09-19 2015-01-07 Histogenics Corporation Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
US8435551B2 (en) 2007-03-06 2013-05-07 Musculoskeletal Transplant Foundation Cancellous construct with support ring for repair of osteochondral defects
WO2009109194A2 (en) 2008-02-29 2009-09-11 Ferrosan A/S Device for promotion of hemostasis and/or wound healing
EP2822474B1 (en) 2012-03-06 2018-05-02 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
EP2825216B1 (en) 2012-06-12 2015-08-19 Ferrosan Medical Devices A/S Dry haemostatic composition
US9724078B2 (en) 2013-06-21 2017-08-08 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
JP6489485B2 (ja) 2013-12-11 2019-03-27 フェロサン メディカル デバイシーズ エイ/エス 押し出し増強因子を含んでいる乾燥組成物
JP6726852B2 (ja) 2014-10-13 2020-07-22 フェッローサン メディカル ディバイス エー/エス 止血および創傷治癒に使用するための乾燥組成物
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
CN107206165B (zh) 2014-12-24 2020-10-23 弗罗桑医疗设备公司 用于保持并混合第一和第二物质的注射器
JP6747651B2 (ja) 2015-07-03 2020-08-26 フェロサン メディカル デバイシーズ エイ/エス 保管状態で真空を保持するための、及び2種の成分を混合するためのシリンジ
KR101841587B1 (ko) 2016-01-12 2018-05-14 주식회사 녹십자홀딩스 피브리노겐의 정제방법
KR20210008479A (ko) 2018-05-09 2021-01-22 훼로산 메디칼 디바이스 에이/에스 지혈 조성물을 제조하는 방법

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993005067A1 (en) * 1991-09-05 1993-03-18 Baxter International, Inc. Topical fibrinogen complex

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993005067A1 (en) * 1991-09-05 1993-03-18 Baxter International, Inc. Topical fibrinogen complex

Also Published As

Publication number Publication date
AU1993795A (en) 1995-10-09
WO1995025748A1 (en) 1995-09-28
EP0699210A1 (en) 1996-03-06
CA2162997A1 (en) 1995-09-28
JPH08512058A (ja) 1996-12-17
JP2896235B2 (ja) 1999-05-31

Similar Documents

Publication Publication Date Title
US5716645A (en) Topical fibrinogen complex
EP0602173B1 (en) Topical fibrinogen complex
AU695266B2 (en) Topical fibrinogen complex
US5605887A (en) Therapeutic fibrinogen compositions
CA2131316C (en) A thrombin blood fraction for use in a medical procedure
CA2201714C (en) Method for isolation of highly pure von willebrand factor
US5578326A (en) Method and an apparatus for preparing tissue repair promoting substances
CN101214391B (zh) 一种高效生物胶封闭剂及其应用
JP2004500026A (ja) 自己由来トロンビン
IL226786A (en) Platelet extract is disabled from viruses, its use and its preparation
EP1043034A1 (en) Adhesive for biological tissue
JP2000509630A (ja) フィブリノーゲンを含む安定化された混合物
WO1992013495A1 (en) Fibrinogen based adhesive
JPH02129224A (ja) フィブリンの製造法
US7211650B2 (en) Purification of fibrinogen from fluids by precipitation and hydrophoic chromatography
KR20040058194A (ko) 보관이 안정한 피브리노겐 용액
CA3009458A1 (en) Methods, compositions and kits for reducing tissue adhesions
EP1057490A2 (en) Use of tranexamic acid for the preparation of a human fibrinogen composition
CA2367124C (en) A thrombin blood fraction for use in a medical procedure
CN1073605A (zh) 通过采用低温沉淀物制备的改善的生物胶
MXPA00004085A (en) Use of tranexamic acid for the preparation of a human fibrinogen composition